Program

Home

T. Arien: NanoTechnology - the Promises and Challenges for Antiretroviral Therapy

Arien

Albertina Ariën PhD is Principal Scientist in Pharmaceutical Development at Johnson and Johnson Pharmaceutical R&D in Beerse, Belgium. Her expertise is in the area of liquid formulation development for oral and parenteral applications. She started working at J&J in 1998 after a 2-year post-doctoral training at the University of Nottingham. In 1995 she received her PhD in Biomedical Sciences
Albertina Ariën is Principal Scientist in Pharmaceutical Development at Johnson and Johnson Pharmaceutical R&D in Beerse, Belgium. Her expertise is in the area of liquid formulation development for oral and parenteral applications. She started working at J&J in 1998 after a 2-year post-doctoral training at the University of Nottingham. In 1995 she received her PhD in Biomedical Sciences at the University of Bordeaux. She has published 31 papers as author or co-author and holds 3 patents.